Murdoch Children’s Research Institute’s (MCRI) World Scabies Program has completed the first round of its mass roll-out of an anti-parasitic drug in the Solomon Islands and Fiji, helping to protect millions from the contagious skin condition. The project, one of the Macquarie 50th Anniversary Award winners, has this year administered scabies treatment, ivermectin, to the population of the two Pacific nations to reduce […]
Read More… from World Scabies Program achieves milestone in Solomon Islands and Fiji